These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8872451)

  • 1. Treatment of hepatic encephalopathy in patients with cirrhosis of the liver.
    Ferenci P
    Dig Dis; 1996; 14 Suppl 1():40-52. PubMed ID: 8872451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The dietary protein contribution and hepatic encephalopathy in cirrhosis].
    Zavaglia C; Brivio M; Losacco E; Onida L
    Recenti Prog Med; 1992 Apr; 83(4):218-23. PubMed ID: 1626117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of portal systemic encephalopathy].
    García Compeán D; Valadez Castillo R; Barragán RF
    Rev Invest Clin; 1990 Jul; 42 Suppl():113-9. PubMed ID: 19256149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasmapheresis and amino acid mixtures of "Aminosteril-Hepa" type preparations in treating hepatic encephalopathy].
    Boroń P; Flisiak R; Bobrowska E; Hilgier W; Szpakowicz T; Pytel B
    Pol Tyg Lek; 1991 Dec 26-30; 46(50-52):984-6. PubMed ID: 1669187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of hepatic encephalopathy. Modification of the plasma aminogram using amino acid infusions].
    Ferenci P; Funovics J; Wewalka F
    Chir Forum Exp Klin Forsch; 1978; (1978):183-9. PubMed ID: 110563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study.
    Egberts EH; Schomerus H; Hamster W; Jürgens P
    Gastroenterology; 1985 Apr; 88(4):887-95. PubMed ID: 3882509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Present-day therapy of hepatic encephalopathy (author's transl)].
    Imler M
    MMW Munch Med Wochenschr; 1976 Dec; 118(52-53):1685-94. PubMed ID: 827698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study.
    Rossi-Fanelli F; Riggio O; Cangiano C; Cascino A; De Conciliis D; Merli M; Stortoni M; Giunchi G
    Dig Dis Sci; 1982 Oct; 27(10):929-35. PubMed ID: 6749458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of post-hemorrhagic hepatic encephalopathy in patients with cirrhosis].
    Doffoël M; Vetter D; Bockel R
    Gastroenterol Clin Biol; 1990; 14(1 ( Pt 2)):29B-33B. PubMed ID: 1968870
    [No Abstract]   [Full Text] [Related]  

  • 11. Concise review of current concepts on nomenclature and pathophysiology of hepatic encephalopathy.
    Savlan I; Liakina V; Valantinas J
    Medicina (Kaunas); 2014; 50(2):75-81. PubMed ID: 25172600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Branched-chain amino acids in the treatment of latent porto-systemic encephalopathy. A placebo-controlled double-blind cross-over study].
    Egberts EH; Schomerus H; Hamster W; Jürgens P
    Z Ernahrungswiss; 1986 Mar; 25(1):9-28. PubMed ID: 3524038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hepatic encephalopathy.
    Riordan SM; Williams R
    N Engl J Med; 1997 Aug; 337(7):473-9. PubMed ID: 9250851
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group.
    Marchesini G; Dioguardi FS; Bianchi GP; Zoli M; Bellati G; Roffi L; Martines D; Abbiati R
    J Hepatol; 1990 Jul; 11(1):92-101. PubMed ID: 2204661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of cirrhotic hepatic encephalopathy. Treatment implications].
    García-Compean D; Michel H
    Rev Gastroenterol Mex; 1995; 60(3):159-68. PubMed ID: 7481451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral supplementation of branched-chain amino acids in patients with hepatic failure].
    Yoshida S; Kakegawa T; Mizote H
    Nihon Rinsho; 1991 Nov; 49 Suppl():204-7. PubMed ID: 1665871
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical study of an enteral branched-chain amino acid solution in decompensated liver cirrhosis with hepatic encephalopathy.
    Ichida T; Shibasaki K; Muto Y; Satoh S; Watanabe A; Ichida F
    Nutrition; 1995; 11(2 Suppl):238-44. PubMed ID: 7626911
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the effects of Hepatic-Aid and a Casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients.
    McGhee A; Henderson JM; Millikan WJ; Bleier JC; Vogel R; Kassouny M; Rudman D
    Ann Surg; 1983 Mar; 197(3):288-93. PubMed ID: 6830337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal-systemic encephalopathy and hepatic coma.
    Jensen DM
    Med Clin North Am; 1986 Sep; 70(5):1081-92. PubMed ID: 2874273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional management of hepatic encephalopathy.
    Bower RH; Fischer JE
    Adv Nutr Res; 1983; 5():1-11. PubMed ID: 6133418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.